Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Short Interest Jumps 382.4%

Innovator IBD 50 ETF (NYSEARCA:FFTY) was the recipient of a large growth in short interest in October. As of October 30th, there was short interest totaling 34,755 shares, a growth of 382.4% from the October 15th total of 7,205 shares. Based on an average daily trading volume, of 36,072 shares, the short-interest ratio is currently 1.0 days. Currently, 2.0% of the shares of the stock are sold short.

Innovator IBD 50 ETF Stock Performance

Innovator IBD 50 ETF stock traded up $0.15 during trading on Wednesday, reaching $29.36. The company had a trading volume of 22,241 shares, compared to its average volume of 49,700. The firm’s 50-day simple moving average is $33.97 and its 200 day simple moving average is $37.24. Innovator IBD 50 ETF has a 1-year low of $28.62 and a 1-year high of $44.08. The firm has a market capitalization of $51.38 million, a PE ratio of 12.03 and a beta of 1.51.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Large investors have recently added to or reduced their stakes in the stock. KFG Wealth Management LLC purchased a new position in Innovator IBD 50 ETF during the second quarter valued at $201,000. Trail Ridge Investment Advisors LLC purchased a new stake in shares of Innovator IBD 50 ETF during the second quarter worth about $210,000. Royal Bank of Canada increased its stake in shares of Innovator IBD 50 ETF by 3,222.5% during the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock worth $611,000 after purchasing an additional 17,724 shares in the last quarter. Guardian Wealth Advisors LLC NC acquired a new position in shares of Innovator IBD 50 ETF during the 2nd quarter worth about $507,000. Finally, WorthPointe LLC raised its position in shares of Innovator IBD 50 ETF by 18.3% during the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after purchasing an additional 3,771 shares during the last quarter.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.